MEDLINE Stock Price, News & Analysis
Company Description
Medline Inc. (Nasdaq: MDLN) is a healthcare company that focuses on medical-surgical ("med-surg") products and supply chain solutions for healthcare providers. According to the company, it is the largest provider of med-surg products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Medline’s activities center on helping healthcare organizations support patient care while addressing clinical, financial and operational needs.
Medline states that it serves a variety of healthcare settings, including hospitals, surgery centers, physician offices and post-acute care facilities. Its offerings include med-surg products and related supply chain services that are used in these environments to support day-to-day patient care and clinical procedures.
Business focus and segments
Based on available information, Medline operates through two primary segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment relates to the company’s own med-surg products, while the Supply Chain Solutions segment relates to services and capabilities that help healthcare providers manage the flow of these products. The company notes that its revenues are generated principally from the sale of its surgical products.
Within med-surg, Medline’s product portfolio includes surgical and procedural kits, gloves and protective apparel, urological and incontinence care products, wound care products, and consumable laboratory and diagnostics products. These products are positioned to support a broad range of clinical activities and care pathways across different types of healthcare facilities.
Role in the healthcare supply chain
Medline emphasizes its combination of a broad product portfolio, a resilient supply chain and what it describes as leading clinical solutions. Through these elements, the company aims to help healthcare providers improve clinical outcomes, manage costs and support operational performance. The focus on supply chain solutions reflects Medline’s role not only as a product supplier but also as a partner in managing product availability and logistics for healthcare organizations.
The company describes itself as serving "all points of care," which encompasses acute care, ambulatory care and post-acute care settings. By working across these settings, Medline positions its med-surg products and supply chain capabilities as relevant to the continuum of patient care.
Public company and listing information
Medline Inc. has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to an initial public offering of its common stock. The company has announced the pricing and closing of an upsized initial public offering of Class A common stock, and its Class A common stock is listed on the Nasdaq Global Select Market under the symbol "MDLN".
The company has indicated that proceeds from the initial public offering are intended for repayment of outstanding indebtedness under senior secured term loan facilities, for general corporate purposes and to cover expenses related to the offering. Medline has also stated that a portion of the proceeds will be used to purchase or redeem outstanding equity interests from certain pre-IPO owners.
Headquarters and global footprint
Medline is headquartered in Northfield, Illinois. The company reports that it employs more than 43,000 people worldwide and operates in more than 100 countries. This global footprint supports its position as a large provider of med-surg products and supply chain solutions to healthcare providers in multiple regions.
Healthcare settings served
According to the company’s description, Medline serves:
- Hospitals that require med-surg products and supply chain support for inpatient and outpatient care.
- Surgery centers that use surgical and procedural kits and related products.
- Physician offices that need consumable products for examinations and minor procedures.
- Post-acute care facilities, which include settings that care for patients after hospitalization.
By working with these settings, Medline aligns its product and supply chain solutions with the practical requirements of healthcare delivery.
Use of med-surg products
Med-surg products are used in a wide range of clinical situations, from routine examinations to complex procedures. Medline’s portfolio, as described in available information, covers areas such as:
- Surgical and procedural kits, which bundle items needed for specific procedures.
- Gloves and protective apparel, which support infection prevention and staff protection.
- Urological and incontinence care, which support patient comfort and care management.
- Wound care, which addresses treatment and management of various wound types.
- Consumable lab and diagnostics products, which support testing and diagnostic workflows.
These categories reflect the company’s focus on products that are regularly consumed in healthcare operations.
IPO and capital structure context
Medline’s initial public offering of Class A common stock represents a transition to trading on a public market. The company has described an upsized offering and the full exercise of underwriters’ options to purchase additional shares. Information in the company’s announcements indicates that the offering is associated with debt repayment and transactions with pre-IPO owners, as well as general corporate purposes.
Investors and analysts interested in Medline can refer to the company’s registration statement on Form S-1 and related prospectus documents for more detailed information about its business, risk factors and financial statements.
Position within healthcare
According to Medline’s own statements, it is the largest provider of med-surg products and supply chain solutions serving all points of care, based on total net sales of med-surg products. This characterization highlights the company’s scale within its specific niche of the healthcare industry. Its combination of med-surg products, supply chain capabilities and clinical solutions is presented as central to its role in supporting healthcare providers.
Stock Performance
MEDLINE (MDLN) stock last traded at $41.36, down 2.35% from the previous close. Over the past 12 months, the stock has gained 0.9%. At a market capitalization of $34.3B, MDLN is classified as a large-cap stock with approximately 1.4B shares outstanding.
Latest News
MEDLINE has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include offering, earnings, earnings date, IPO. View all MDLN news →
SEC Filings
MEDLINE has filed 5 recent SEC filings, including 5 Form 4. The most recent filing was submitted on March 13, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MDLN SEC filings →
Insider Radar
Insider selling at MEDLINE over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
MEDLINE generated $28.4B in revenue over the trailing twelve months, retaining a 26.4% gross margin, operating income reached $2.2B (7.8% operating margin), and net income was $1.2B, reflecting a 4.1% net profit margin. Diluted earnings per share stood at $-0.01. The company generated $1.7B in operating cash flow. With a current ratio of 4.29, the balance sheet reflects a strong liquidity position.
Upcoming Events
Midlothian distribution center operational
MEDLINE has 1 upcoming scheduled event. The next event, "Midlothian distribution center operational", is scheduled for April 1, 2027 (in 369 days). Investors can track these dates to stay informed about potential catalysts that may affect the MDLN stock price.
Short Interest History
Short interest in MEDLINE (MDLN) currently stands at 6.8 million shares, up 14.5% from the previous reporting period, representing 3.2% of the float. Over the past 12 months, short interest has decreased by 47%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for MEDLINE (MDLN) currently stands at 2.3 days, up 81.9% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 131% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.3 days.
MDLN Company Profile & Sector Positioning
MEDLINE (MDLN) operates in the Medical Instruments & Supplies industry within the broader Surgical & Medical Instruments & Apparatus sector and is listed on the NASDAQ.